D. Watson

D. Blair, G. Mavrothalassitis, D. Watson, 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Hu-ets-1 and Hu-ets-2 genes are transposed in acute leukemias with (4;11) and (8;21) translocations.

A. Hagemeijer, D. Patterson, D. Watson, 1986, Science.

Novel role of thromboxane receptors beta isoform in bladder cancer pathogenesis.

E. Garrett-Mayer, D. Watson, P. Halushka, 2008, Cancer research.

Inhibition of thromboxane synthase activity modulates bladder cancer cell responses to chemotherapeutic agents

D. Watson, P. Halushka, O. Moussa, 2008, Oncogene.

Multivariate models from RNA-Seq SNVs yield candidate molecular targets for biomarker discovery: SNV-DA

P. Watson, D. Watson, C. Denlinger, 2016, BMC Genomics.

Triplex DNA-mediated downregulation of Ets2 expression results in growth inhibition and apoptosis in human prostate cancer cells.

F. Cavalli, A. Valentini, D. Watson, 2004, Nucleic acids research.

Molecular and functional characterization of the promoter of ETS2, the human c-ets-2 gene.

G. Mavrothalassitis, D. Watson, T. Papas, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Kaposi's Sarcoma-Associated Herpesvirus Suppression of DUSP1 Facilitates Cellular Pathogenesis following De Novo Infection

F. Peruzzi, B. Toole, Z. Qin, 2012, Journal of Virology.

Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineage

Elizabeth A. Kruse, P. Nurden, W. Alexander, 2009, Proceedings of the National Academy of Sciences.

Induction of hematopoietic and endothelial cell program orchestrated by ETS transcription factor ER71/ETV2

Daofeng Li, Ting Wang, D. Watson, 2015, EMBO reports.

The Transcription Factor Fli-1 Modulates Marginal Zone and Follicular B Cell Development in Mice1

G. Gilkeson, A. Larue, D. Watson, 2008, The Journal of Immunology.

Hemorrhage, Impaired Hematopoiesis, and Lethality in Mouse Embryos Carrying a Targeted Disruption of the Fli1Transcription Factor

D. Watson, M. Ogawa, P. Jackers, 2000, Molecular and Cellular Biology.

Epithelial to mesenchymal transition and the cancer stem cell phenotype: Insights from cancer biology with therapeutic implications for colorectal cancer

V. Findlay, D. Watson, E. Camp, 2014, Cancer Gene Therapy.

ETS Transcription Factor Expression and Conversion During Prostate and Breast Cancer Progression

V. Findlay, D. Turner, P. Watson, 2010 .

ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer

D. Turner, D. Watson, 2008, Expert review of anticancer therapy.

Defects of DNA mismatch repair in human prostate cancer.

D. Watson, J. Wang, Jiansong Wang, 2001, Cancer research.

Cellular myc (c-myc) in fish (rainbow trout): its relationship to other vertebrate myc genes and to the transforming genes of the MC29 family of viruses.

J. Lautenberger, R. V. Van Beneden, D. Watson, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Predictive modeling of lung cancer recurrence using alternative splicing events versus differential expression data

Paul E. Anderson, Robert C. Wilson, Paul E. Anderson, 2014, 2014 IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology.

The cellular ets genes: molecular biology and clinical implications in human leukemias.

S. O’Brien, D. Watson, N. Sacchi, 1986, Cancer investigation.

Hematopoietic Stem Cell–Derived Cancer–Associated Fibroblasts Are Novel Contributors to the Pro-Tumorigenic Microenvironment

Jeffrey A Jones, V. Findlay, A. Larue, 2015, Neoplasia.

Suppression of the Ewing’s sarcoma phenotype by FLI1/ERF repressor hybrids

D. Blair, G. Mavrothalassitis, D. Watson, 2000, Cancer Gene Therapy.

Maturation stage-specific regulation of megakaryopoiesis by pointed-domain Ets proteins.

W. Leonard, G. Blobel, M. Poncz, 2005, Blood.

CaSm (LSm-1) overexpression in lung cancer and mesothelioma is required for transformed phenotypes.

P. Watson, D. Watson, D. Cole, 2008, American journal of respiratory cell and molecular biology.

CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability.

P. Nelson, P. Watson, D. Watson, 2005, Cancer research.

Transcription Factor Ets-1 Regulates Fibroblast Growth Factor-1-Mediated Angiogenesis in vivo: Role of Ets-1 in the Regulation of the PI3K/AKT/MMP-1 Pathway

B. Weylie, James Zhu, R. Forough, 2006, Journal of Vascular Research.

The Mammalian ETS Genes: Two Unique Chromosomal Locations in Cat, Mice and Man and Novel Translocated Position in Human Leukemias

D. Watson, N. Sacchi, T. Papas, 1986 .

Review Molecular mechanisms of megakaryopoiesis

A. Larue, D. Watson, G. Szalai, 2006 .

Ets-dependent Regulation of Target Gene Expression during Megakaryopoiesis*

D. Watson, P. Jackers, O. Moussa, 2004, Journal of Biological Chemistry.

Regulation of Ets function by protein–protein interactions

Runzhao Li, D. Watson, H. Pei, 2000, Oncogene.

The cancer-associated Sm-like oncogene: a novel target for the gene therapy of pancreatic cancer.

D. Watson, D. Cole, J. Vournakis, 2000, Surgery.

The ets sequence from the transforming gene of avian erythroblastosis virus, E26, has unique domains on human chromosomes 11 and 21: both loci are transcriptionally active.

S. O’Brien, P. Duesberg, D. Watson, 1985, Proceedings of the National Academy of Sciences of the United States of America.

ETS2 function is required to maintain the transformed state of human prostate cancer cells

V. Sementchenko, D. Watson, T. Papas, 1998, Oncogene.

c-ets-2 protooncogene has mitogenic and oncogenic activity.

A. Seth, D. Blair, D. Watson, 1989, Proceedings of the National Academy of Sciences of the United States of America.

The avian and mammalian ets genes: molecular characterization, chromosome mapping, and implication in human leukemia.

S. O’Brien, D. Watson, N. Sacchi, 1986, Anticancer research.

Mammalian ets-1 and ets-2 genes encode highly conserved proteins.

J. Lautenberger, D. Watson, T. Papas, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Conserved chromosomal positions of dual domains of the ets protooncogene in cats, mice, and humans.

S. O’Brien, W. Nash, W. Nash, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Molecular analysis of the ets genes and their products.

D. Watson, T. Papas, R. Ascione, 1990, Critical reviews in oncogenesis.

Bystander effect contributes to the antitumor efficacy of CaSm antisense gene therapy in a preclinical model of advanced pancreatic cancer.

W. Gillanders, D. Watson, D. Cole, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Detection of Chromosomal Aberrations in Transitional Cell Carcinoma of the Bladder by Representational Difference Analysis.

D. Watson, M. Ghoneim, N. Bissada, 2004, Cancer genomics & proteomics.

Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression

David P Turner, V. Findlay, A. Larue, 2011, The Prostate.

Abstract B13: Hematopoietic stem cell-derived cancer-associated fibroblasts are novel contributors to the pro-tumorigenic microenvironment

Jeffrey A Jones, V. Findlay, A. Larue, 2015 .

Hematopoietic Stem Cell-Derived Cancer-Associated Fibroblasts Are Novel Contributors to the

Jeffrey A Jones, South S. Carolina, V. Findlay, 2015 .

Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy.

D. Watson, Larisa V. Fedorova, J. Shapiro, 2009, American journal of physiology. Renal physiology.

Hematopoietic stem cell origin of adipocytes.

A. Larue, P. Watson, D. Watson, 2009, Experimental hematology.

FLI1 Expression is Correlated with Breast Cancer Cellular Growth, Migration, and Invasion and Altered Gene Expression

V. Findlay, P. Watson, D. Watson, 2014, Neoplasia.

Transcription Factor Fli1 Regulates Collagen Fibrillogenesis in Mouse Skin

D. Watson, Y. Asano, M. Markiewicz, 2008, Molecular and Cellular Biology.

SNAI2 Modulates Colorectal Cancer 5-Fluorouracil Sensitivity through miR145 Repression

Lourdes M. Nogueira, S. Ethier, V. Findlay, 2014, Molecular Cancer Therapeutics.

SNAI 2 modulates colorectal cancer 5-fluorouracil sensitivity through miR 145 repression

Stephen, Lourdes M. Nogueira, V. Findlay, 2014 .

PDEF is a negative regulator of colon cancer cell growth and migration

David P Turner, V. Sementchenko, D. Turner, 2009, Journal of cellular biochemistry.

Thrombocytopenia in Mice Lacking the Carboxy-Terminal Regulatory Domain of the Ets Transcription Factor Fli1

G. Gilkeson, A. Larue, D. Watson, 2010, Molecular and Cellular Biology.

Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer.

David P Turner, P. Fisher, D. Turner, 2007, Cancer research.

Fli1 Acts Downstream of Etv2 to Govern Cell Survival and Vascular Homeostasis via Positive Autoregulation

J. Shelton, D. Watson, N. Jiang, 2014, Circulation research.

Real‐time DNA binding measurements of the ETSl recombinant oncoproteins reveal significant kinetic differences between the p42 and p51 isoforms

J. Erickson, J. Casas-Finet, R. Fisher, 1994, Protein science : a publication of the Protein Society.

FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements

I. Kola, A. Seth, D. Watson, 1997, Oncogene.

The transforming gene of avian myeloblastosis virus (AMV): nucleotide sequence analysis and identification of its translational product.

E. Reddy, D. Watson, T. Papas, 1983, Haematology and blood transfusion.

MicroRNA 204 mediated negative regulation of the IGF2R promotes breast cancer progression and is a potential mechanism driving breast cancer disparity

Lourdes M. Nogueira, K. Helke, E. Garrett-Mayer, 2013 .

Loss of Expression and Function of SOCS3 Is an Early Event in HNSCC: Altered Subcellular Localization as a Possible Mechanism Involved in Proliferation, Migration and Invasion

S. Rosenzweig, D. Watson, L. C. Spolidorio, 2012, PloS one.

Nucleotide sequence analysis of human c-myc locus, chicken homologue, and myelocytomatosis virus MC29 transforming gene reveals a highly conserved gene product.

D. Watson, T. Papas, M. Psallidopoulos, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer.

D. Sinha, D. Watson, P. Halushka, 2005, Cancer research.

Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer.

D. Sinha, D. Watson, P. Halushka, 2005, Cancer research.

Establishing a murine pancreatic cancer CaSm model: up-regulation of CaSm is required for the transformed phenotype of murine pancreatic adenocarcinoma.

W. Gillanders, P. Watson, D. Watson, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Histone-dependent reconstitution and nucleosomal localization of a nonhistone chromosomal protein: the H2A-specific protease.

E. Moudrianakis, D. Watson, 1982, Biochemistry.

Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia.

Steven M Kornblau, Kevin R Coombes, K. Coombes, 2011, Blood.

Slug expression inhibits calcitriol‐mediated sensitivity to radiation in colorectal cancer

V. Findlay, D. Watson, E. Camp, 2014, Molecular carcinogenesis.

Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression.

V. Findlay, D. Turner, D. Watson, 2008, Molecular biology of the cell.

Essential Components of Cancer Education.

H. Nakshatri, R. Jensen, A. Riegel, 2015, Cancer Research.

Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer.

D. Watson, M. Ghoneim, N. Bissada, 2006, The Journal of urology.

Functional relationships among ETS gene family members.

N. Bhat, A. Seth, D. Watson, 1997, Leukemia.

Expression of human and viral ets genes in E. coli production of human ets-2-specific monoclonal antibodies.

A. Seth, D. Watson, T. Papas, 1989, Oncogene research.

Expression of ETS Family of Genes in Systemic Lupus Erythematosis

N. Bhat, D. Watson, Papas Ts, 2000 .

Structural inferences of the ETS1 DNA-binding domain determined by mutational analysis.

R. Fisher, G. Mavrothalassitis, D. Watson, 1994, Oncogene.

ETS family proteins activate transcription from HIV-1 long terminal repeat.

A. Seth, D. Watson, T. Papas, 1993, AIDS research and human retroviruses.

The FLI-1 transcription factor is a short-lived phosphoprotein in T cells.

D. Watson, Xian K Zhang, 2005, Journal of Biochemistry (Tokyo).

Viral myc genes and their cellular homologs.

J. Lautenberger, R. V. Van Beneden, R. Fisher, 1986, Gene amplification and analysis.

DEACT: An Online Tool for Analysing Complementary RNA-Seq Studies - A Case Study of Knockdown and Upregulated FLI1 in Breast Cancer Cells

Margaret L. Antonio, Paul E. Anderson, Dennis K. Watson, 2017, BIOINFORMATICS.

Breast Cancer Potential through the Inhibition of Migration and Invasion in Prostate-Derived ETS Factor Is a Mediator of Metastatic

David P Turner, P. Fisher, D. Turner, 2007 .

Complementary feature selection from alternative splicing events and gene expression for phenotype prediction

Margaret L. Antonio, Paul E. Anderson, Robert C. Wilson, 2016, Bioinform..

Genomic dispersal of the ets gene family during metazoan evolution.

S. O’Brien, J. Lautenberger, D. Watson, 1992, Oncogene.

Interaction of ETS-1 and ERGB/FLI-1 proteins with DNA is modulated by spacing between multiple binding sites as well as phosphorylation.

J. Lautenberger, A. Seth, M. Venanzoni, 1996, Oncogene.

Marker-assisted study of genetic background and gene-targeted locus modifiers in lymphopoietic phenotypes.

F. Bartel, D. Watson, M. Ogawa, 2003, Anticancer research.

Multivariate models from RNA-Seq SNVs yield candidate molecular targets for biomarker discovery: SNV-DA

P. Watson, D. Watson, R. Wilson, 2016, BMC Genomics.

Rationale: Cardiovascular Health Depends on Proper Development and Integrity of Blood Vessels. Ets Variant 2 (etv2), Methods and Results: Using Loss-and Gain-of-function Strategies and a Series of Molecular Techniques, We Identify Friend Leukemia Integration 1 (fli1), Another E26 Transforming–specif

J. Shelton, D. Watson, N. Jiang, 2022 .